BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 2450694)

  • 1. Synthesis and characterization of a novel tritiated KATP channel opener with a benzopyran structure.
    Manley PW; Löffler-Walz C; Russ U; Hambrock A; Moenius T; Quast U
    Br J Pharmacol; 2001 May; 133(2):275-85. PubMed ID: 11350864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRL 38227 (levcromakalim)-induced hyperpolarization reduces the sensitivity to Ca2+ of contractile elements in canine coronary artery.
    Okada Y; Yanagisawa T; Taira N
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):438-44. PubMed ID: 8510771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of (-)-cromakalim and glibenclamide on uptake2 in guinea-pig trachealis muscle.
    Bryan-Lluka LJ; Vuocolo HE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):65-9. PubMed ID: 8377841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cromakalim inhibits electrically-evoked [3H]acetylcholine release from a tube-preparation of the rat isolated trachea by an epithelium-dependent mechanism.
    Wessler I; Hölz C; Maclagan J; Pohan D; Reinheimer T; Racké K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):14-20. PubMed ID: 8377836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.
    Ushio-Fukai M; Hirano K; Kanaide H
    Br J Pharmacol; 1994 Dec; 113(4):1173-82. PubMed ID: 7889270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue.
    Quast U; Baumlin Y
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):319-26. PubMed ID: 3194039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta--comparison with the calcium antagonist isradipine.
    Cook NS; Weir SW; Danzeisen MC
    Br J Pharmacol; 1988 Nov; 95(3):741-52. PubMed ID: 2974739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH
    Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.
    Smallwood JK; Robertson DW; Steinberg MI
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):625-9. PubMed ID: 2505091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial vasodilating profile and biological effects of pinacidil in healthy volunteers.
    Thuillez C; Pussard E; Bellissant E; Richer C; Kechrid R; Giudicelli JF
    Br J Clin Pharmacol; 1991 Jan; 31(1):33-9. PubMed ID: 2015168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of depolarizing and hyperpolarizing agents on the membrane potential difference of primary cultures of rabbit aorta vascular smooth muscle cells.
    Pavenstädt H; Lindeman V; Lindeman S; Kunzelmann K; Späth M; Greger R
    Pflugers Arch; 1991 Aug; 419(1):69-75. PubMed ID: 1945763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spasmolytic effect of cromakalim in dog coronary artery in vitro.
    McPherson GA; Keily SG; Angus JA
    Naunyn Schmiedebergs Arch Pharmacol; 1991 May; 343(5):519-24. PubMed ID: 1908952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of lemakalim on changes in Ca2+ concentration and mechanical activity induced by noradrenaline in the rabbit mesenteric artery.
    Ito S; Kajikuri J; Itoh T; Kuriyama H
    Br J Pharmacol; 1991 Sep; 104(1):227-33. PubMed ID: 1786512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The resistance of some rat cerebral arteries to the vasorelaxant effect of cromakalim and other K+ channel openers.
    McPherson GA; Stork AP
    Br J Pharmacol; 1992 Jan; 105(1):51-8. PubMed ID: 1534504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution.
    Duty S; Weston AH
    Br J Pharmacol; 1992 Dec; 107(4):1198-204. PubMed ID: 1467840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cromakalim on the membrane potassium permeability of frog skeletal muscle in vitro.
    Benton DC; Haylett DG
    Br J Pharmacol; 1992 Sep; 107(1):152-5. PubMed ID: 1422569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of several potassium-channel openers on rat bladder and rat portal vein in vitro.
    Edwards G; Henshaw M; Miller M; Weston AH
    Br J Pharmacol; 1991 Mar; 102(3):679-86. PubMed ID: 1364839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action and systemic and regional hemodynamics of the potassium channel activator BRL34915 and its enantiomers.
    Hof RP; Quast U; Cook NS; Blarer S
    Circ Res; 1988 Apr; 62(4):679-86. PubMed ID: 2450694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities in the mechanism of action of two new vasodilator drugs: pinacidil and BRL 34915.
    Cook NS; Quast U; Hof RP; Baumlin Y; Pally C
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):90-9. PubMed ID: 2450263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.